Glasgow Royal Infirmary, Renal Unit.
Nephrol Dial Transplant. 2010 May;25(5):1596-604. doi: 10.1093/ndt/gfp667. Epub 2010 Jan 6.
Central venous catheterization is a fundamental component in delivering haemodialysis yet is associated with significantly higher complication rates than other methods of vascular access. In this study, we report results of univariate and multivariate analyses designed to identify and quantify independent risk association for catheterization type, clinical variables and laboratory variables with regard to the development of catheter-related bacteraemia (CRB) and catheter failure due to poor haemodialysis flow.
A 2-year prospective study of all incident haemodialysis vascular access catheter insertions was conducted. Laboratory and clinical variables were recorded at catheter insertion, and the clinical course was followed up to the point of catheter removal. CRB and catheter failure due to poor flow were recorded as outcome events. Univariate and multivariate analyses were used to test for association between clinical and laboratory variables and outcome.
Forty-four thousand five hundred seventy-six catheter days were accumulated over the study period. Multivariate analysis demonstrated an independent association between non-tunnelled catheterization procedures and adverse outcomes compared with tunnelled central venous catheter insertions. Elevated modified Charlson comorbidity score was independently associated with the development of CRBc. Elevated C-reactive protein and low haemodialysis blood pump flow were independently associated with catheter failure due to poor flow.
The data demonstrate that tunnelled central venous catheter insertions have an association with lower complication rates than non-tunnelled central venous catheter insertions that is independent of whether patients have acute or chronic renal failure, or high levels of comorbidity.
中心静脉导管置管术是血液透析的基本组成部分,但与其他血管通路方法相比,其并发症发生率明显更高。在这项研究中,我们报告了单变量和多变量分析的结果,旨在确定并量化导管类型、临床变量和实验室变量与导管相关性菌血症(CRB)和因血液透析流量差而导致的导管故障的独立风险关联。
对所有新发生的血液透析血管通路导管插入术进行了为期 2 年的前瞻性研究。在导管插入时记录实验室和临床变量,并对临床过程进行随访,直至导管取出。将 CRB 和因流量差而导致的导管故障记录为结局事件。使用单变量和多变量分析来测试临床和实验室变量与结局之间的关联。
在研究期间积累了 44576 个导管日。多变量分析表明,与隧道式中心静脉导管插入术相比,非隧道式导管置管术与不良结局之间存在独立关联。改良 Charlson 合并症评分升高与 CRBc 的发生独立相关。C 反应蛋白升高和血液透析血液泵流量低与因流量差而导致的导管故障独立相关。
数据表明,隧道式中心静脉导管插入术与非隧道式中心静脉导管插入术相比,并发症发生率较低,这与患者是急性还是慢性肾衰竭以及合并症的严重程度无关。